test

Clinical Trials

Melanoma

10
A Phase I, Open-Label Clinical Trial Evaluating the Safety, Tolerability and Immunogenicity of Intradermally Administered ID-LV305 in Patients with Locally Advanced, Relapsed, or Metastatic Cancer Expressing NY-ESO-1
Disease/Condition: Breast - Female | Kaposi's sarcoma | Lung | Melanoma, skin | Ovary | Soft Tissue
Principal Investigator: Joseph Kim
A Phase I/II Study to Assess the Safety and Activity of Enhanced TCR Transduced Autologous T cells against Cancer-testis Antigens in Metastatic Melanoma
Disease/Condition: Melanoma, skin
Principal Investigator: Harriet Kluger
A Phase I/II Trial of Evaluating the Combination of MK-3475 and Stereotactic Body Radiotherapy in Patients with Metastatic Melanoma or NSCLC
Disease/Condition: Lung | Melanoma, skin
Principal Investigator: Roy Decker
A Phase II Study of MK-3475 in Patients with Metastatic Melanoma or Non-Small Cell Lung Cancer with Untreated Brain Metastases
Disease/Condition: Lung | Melanoma, skin
Principal Investigator: Harriet Kluger
Expanded Access of MK-3475 in Metastatic Melanoma Patients with Limited to No Treatment Options
Principal Investigator: Mario Sznol
Phase I Study of BVD-523 in Patients with Advanced Malignancies
Disease/Condition: Melanoma, skin
Stand Up to Cancer Consortium Genomics-Enabled Medicine for Melanoma (G.E.M.M.): Using Molecularly-Guided Therapy for Patients With BRAF Wild-Type (BRAFwt) Metastatic Melanoma
Disease/Condition: Melanoma, skin
Principal Investigator: Harriet Kluger